Akèy › Maladi Alzheimer › Texas › Dallas
Etid klinik pou Maladi Alzheimer nan Dallas, TX
12 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Ap rekriteFaz 2
- Kerwin Medical Center- Site Number : 8400006, Dallas
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Ap rekriteFaz 3
- Local Institution - 1260, Dallas
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
- Kerwin Medical Center, Dallas
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Ap rekriteFaz 2
- Kerwin Research Center, LLC - Oak Cliff, Dallas
- Kerwin Research Center, LLC in Texas, Dallas
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Ap rekriteFaz 3
- Kerwin Medical Center, Dallas
- Kerwin Research Center, LLC, Dallas
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Ap rekriteFaz 1/2
- Kerwin Medical Center /ID# 277788, Dallas
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Ap rekriteFaz 3
- Local Institution - 0081, Dallas
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
- University of Texas Southwestern, Dallas
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Ap rekriteFaz 2/3Volontè an sante akeyi
- Kerwin Research and Memory Center, Dallas
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Ap rekriteFaz 2/3Volontè an sante akeyi
- Kerwin Research and Memory Center, Dallas
[18F]PI-2620 Phase 3 Histopathological Study
Ap rekriteFaz 3
- Baylor Research Institute, Dallas
Late Onset Alzheimer's Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Texas Southwestern, Dallas
Etid Maladi Alzheimer nan lòt vil
- Boston, MA26 etid
- Orlando, FL25 etid
- St. Louis, MO22 etid
- New York City, NY21 etid
- Miami, FL20 etid
- Tampa, FL17 etid
- Atlanta, GA16 etid
- The Villages, FL15 etid
- Philadelphia, PA15 etid
- Phoenix, AZ15 etid
- Indianapolis, IN14 etid
- Los Angeles, CA14 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè poumon27 etid
- Kansè vejik27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.